Curanex Pharmaceuticals Inc (CURX)
8.60
+0.41 (4.95%)
Inactive · Last trade price on Sep 12, 2025

Curanex Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Net Income
-0.44-0.36-0.02-0.02
Depreciation & Amortization
0.03-00.02
Asset Writedown & Restructuring Costs
0.070.07--
Change in Inventory
--00.02
Change in Accounts Payable
00.01--
Change in Other Net Operating Assets
-0.33-0.270.01-0.02
Operating Cash Flow
-0.67-0.56-00
Short-Term Debt Issued
--0-
Total Debt Issued
0.4-0-
Short-Term Debt Repaid
----0
Total Debt Repaid
----0
Net Debt Issued (Repaid)
0.4-0-0
Issuance of Common Stock
-0.630.07-
Financing Cash Flow
0.40.630.07-0
Net Cash Flow
-0.270.070.070
Levered Free Cash Flow
-0.5-0.55--
Unlevered Free Cash Flow
-0.5-0.55--
Change in Working Capital
-0.33-0.270.020
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q